The University of Chicago Header Logo

Connection

Richard A. Larson to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Angiogenesis Inhibitors.
Richard A. Larson
Connection Strength
0.333
Angiogenesis Inhibitors
  1. Myelodysplasia: when to treat and how. Best Pract Res Clin Haematol. 2006; 19(2):293-300.
    View in: PubMed
    Score: 0.228
  2. Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance). Br J Clin Pharmacol. 2014 Nov; 78(5):1005-13.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.